Related references
Note: Only part of the references are listed.Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA
Mary Jo Lund et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California, 1999-2004
Carol A. Parise et al.
BREAST JOURNAL (2009)
Breast Cancer Receptor Status: Do Results from a Centralized Pathology Laboratory Agree with SEER Registry Reports?
Huiyan Ma et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast Cancer
Dezheng Huo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors
Marilyn L. Kwan et al.
BREAST CANCER RESEARCH (2009)
Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
Maggie C. U. Cheang et al.
CLINICAL CANCER RESEARCH (2008)
Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the US
Barry A. Miller et al.
CANCER CAUSES & CONTROL (2008)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
Marc Tischkowitz et al.
BMC CANCER (2007)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
Recent trends in breast cancer incidence among 6 Asian groups in the Greater Bay Area of Northern California
Theresa H. M. Keegan et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
A cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER2/neu-positive breast cancer
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance
Emad A. Rakha et al.
EUROPEAN JOURNAL OF CANCER (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years
BH Son et al.
ARCHIVES OF SURGERY (2006)
Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in Taiwan
XH Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Bias in completeness of birthplace data for Asian groups in a population-based cancer registry (United States)
SL Gomez et al.
CANCER CAUSES & CONTROL (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Young age: an independent risk factor for disease-free survival in women with operable breast cancer
WS Han et al.
BMC CANCER (2004)
Hospital policy and practice regarding the collection of data on race, ethnicity, and birthplace
SL Gomez et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2003)
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
WD Foulkes et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Time trends in cancer mortality in China: 1987-1999
L Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Differences in breast cancer stage, treatment, and survival by race and ethnicity
CI Li et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Hereditary breast and ovarian cancer in Asia:: Genetic epidemiology of BRCA1 and BRCA2
A Liede et al.
HUMAN MUTATION (2002)
The pathology of familial breast cancer:: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2
SR Lakhani et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Socioeconomic status and breast cancer incidence in California for different race/ethnic groups
K Yost et al.
CANCER CAUSES & CONTROL (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
